We are proud to announce the upcoming acquisition of our new pharmaceutical division. In addition, Folium Biosciences is entering into joint venture partnerships with hospitals, healthcare teaching facilities, and universities. Folium Biosciences will be engaging in clinical and pharmacology studies, both domestically and internationally.
2019 will also see the construction of Folium Biosciences’ new 170K sq. ft. Canadian facility, with licensing throughout the Queen’s commonwealth. South American facilities are in the developing stages.
Our Passion & Approach
Quality, Consistency, & Transparency is our business.
We pride ourselves on quality, consistency, and transparency from our hemp to the processing of our THC Free (0.0%) Broad Spectrum CBD Oil in our state-of-the-art extraction and purification facilities. Our vertical integration and rigorous quality control allows us to create the best bulk CBD products with the highest potencies and purity. We know how important it is to control the entire supply chain and are dedicated to the transparency and integrity of our entire ‘seed to sale’ process.